Intra-Cellular Therapies
ITCI
#1799
Rank
A$14.58 B
Marketcap
$137.60
Share price
2.17%
Change (1 day)
41.24%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: A$14.58 Billion

As of December 2024 Intra-Cellular Therapies has a market cap of A$14.58 Billion. This makes Intra-Cellular Therapies the world's 1799th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024A$14.58 B44.19%
2023A$10.11 B37.37%
2022A$7.36 B25.23%
2021A$5.88 B76.74%
2020A$3.32 B22.33%
2019A$2.72 B206.47%
2018A$0.88 B-12.32%
2017A$1.01 B11.76%
2016A$0.90 B-71.57%
2015A$3.18 B400.87%
2014A$0.63 B28.04%
2013A$0.49 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

A$14.58 Billion
by Nasdaq info icon info icon
A$14.58 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.16 B-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$46.22 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.77 B-80.99%๐Ÿ‡บ๐Ÿ‡ธ USA